SkinHealth Systems Inc-A 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March31, 2026☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from __________ to__________.Commission File Number: 001-39565 SkinHealth Systems Inc.(Exact name of registrant as specified in its charter) 85-1908962 (I.R.S. Employer Identification No.) The Beauty Health Company2165 Spring Street, Long Beach, CA 90806(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered The Nasdaq Capital Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) hasbeen subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”,and “emerging growth company” in Rule 12b-2 of the Exchange Act.☐☒ Accelerated filerSmaller reporting company☐Emerging growth company☐ Large accelerated filerNon-accelerated filer☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of May5, 2026, there were 129,600,040 shares of Class A Common Stock, par value $0.0001 per share issued and outstanding. SKINHEALTH SYSTEMS INC.FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2026TABLE OF CONTENTS PagePART I—FINANCIAL INFORMATIONItem 1.Financial Statements3Condensed Consolidated Balance Sheets (Unaudited)3Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)4Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)5Condensed Consolidated Statements of Cash Flows (Unaudited)6Notes to Condensed Consolidated Financial Statements (Unaudited)7Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations24Item 3.Quantitative and Qualitative Disclosures About Market Risk31Item 4.Controls and Procedures31PART II—OTHER INFORMATIONItem 1.Legal Proceedings32Item 1A.Risk Factors40Item 2.Unregistered Sales of Equity Securities and Use of Proceeds40Item 3.Defaults Upon Senior Securities40Item 4.Mine Safety Disclosures40Item 5.Other Information40Item 6.Exhibits41SIGNATURES SKINHEALTH SYSTEMS INC.CONDENSED CONSOLIDATEDBALANCE SHEETS(in thousands, except for share amounts)(Unaudited) SKINHEALTH SYSTEMS INC.CONDENSED CONSOLIDATEDSTATEMENTS OF COMPREHENSIVE INCOME (LOSS)(in thousands, except for share and per share amounts)(Unaudited) The accompanying notes are an integral part of these unaudited financial statements. SKINHEALTH SYSTEMS INC.CONDENSED CONSOLIDATEDSTATEMENTS OF CASH FLOWS(in thousands)(Unaudited) SKINHEALTH SYSTEMS INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 1 — Description of Business SkinHealth Systems Inc. (the “Company”) is a global medical aesthetics company delivering an integrated ecosystem of clinicallyproven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial, aleading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylusmicroneedling and HydraScalp powered by Keravive, the Company combines advanced device technology, proprietary consumables, andclinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Historical Information The Company (previously, The Beauty Health Company, and formerly, Vesper Healthcare Acquisition Corp.) was incorporated in theState of Delaware on July 8, 2020. On May 4, 2021, we consummated the business combination pursuant to that certain Agreement andPlan of Merger, dated December 8, 2020, by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc. (“Merger SubI”), Hydrate Merger Sub II, LLC (“Merger Sub II”), LCP Edge Intermediate, Inc., the indirect parent of HydraFacial LLC, f.k.a